Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(6.46) per share. This is a 80.97 percent increase over losses of $(33.94) per share from the same period last year.
Related Posts
CME Group To Launch Cobalt Hydroxide Futures On October 23
CME Group, the world's leading derivatives marketplace, today announced that it will launch Cobalt Hydroxide futures on October 23, pending all relevant regulatory reviews. This is the fourth battery metals futures
Bitcoin, Ethereum, Dogecoin Gain After Inflation Data: Analyst Sees $30K For Apex Crypto As ‘Fed’s Work Is Almost Done’
Major cryptocurrencies traded in the green late on Tuesday after the release of the February Consumer Price Index, which showed a decline in inflation to 6% from the previous month's reading of 6.4%.
Smart for Life Announces 1-For-3 Reverse Stock Split
Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced